Bluejay diagnostics, inc. reports second quarter 2022 financial results

Acton, mass., july 26, 2022 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease progression, today announced financial results for the quarter and six months ended june 30, 2022.
BJDX Ratings Summary
BJDX Quant Ranking